US5719302A
(en)
*
|
1993-04-29 |
1998-02-17 |
Pronova A.S |
Processes for chromatographic fractionation of fatty acids and their derivatives
|
TR199900786T2
(xx)
|
1996-10-11 |
1999-07-21 |
Scotia Holdings Plc |
Eykoza penta enoik asit ve/veya stearidonik asit i�eren farmas�tik terkipler.
|
JP2872986B1
(ja)
*
|
1998-01-21 |
1999-03-24 |
池田食研株式会社 |
高純度高度不飽和脂肪酸の低級アルコールエステル精製方法
|
GB9901809D0
(en)
|
1999-01-27 |
1999-03-17 |
Scarista Limited |
Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
|
WO2000050547A1
(en)
|
1999-02-26 |
2000-08-31 |
Monsanto Company |
Process for separating a triglyceride comprising a docosahexaenoic acid residue from a mixture of triglycerides
|
ES2159257B1
(es)
*
|
1999-11-19 |
2002-04-16 |
Kd Iqa S L |
Nuevo procedimiento de preparacion del ester etilico del acido eicosa pentaenoico.
|
EP1125914A1
(en)
*
|
2000-02-14 |
2001-08-22 |
Nisshin Flour Milling Co., Ltd. |
Process for separating and purifying eicosapentaenoic acid or its ester
|
FR2833006A1
(fr)
*
|
2001-11-30 |
2003-06-06 |
Cognis France Sa |
Procede de preparation d'ester methylique d'acide oleique industriel
|
JP4109893B2
(ja)
*
|
2002-04-24 |
2008-07-02 |
株式会社日本触媒 |
アジリジン類およびn−ビニルアミド類の製造方法
|
ITMI20030573A1
(it)
*
|
2003-03-24 |
2004-09-25 |
Nikem Research Srl |
Composti ad azione nootropica, loro preparazione,
|
CA2655956A1
(en)
*
|
2006-06-23 |
2007-12-27 |
The Procter & Gamble Company |
Concentrated and odorless omega 3 fatty acids
|
KR101357298B1
(ko)
*
|
2008-06-20 |
2014-01-28 |
에이케이 앤 엠엔 바이오팜 주식회사 |
오메가-3계 고도불포화 지방산의 고순도 정제방법
|
PT2334295T
(pt)
|
2008-09-02 |
2017-09-15 |
Amarin Pharmaceuticals Ie Ltd |
Composição farmacêutica compreendendo ácido eicosapentanoico e ácido nicotínico e métodos de utilização dos mesmos
|
LT2596786T
(lt)
|
2009-02-10 |
2020-01-10 |
Amarin Pharmaceuticals Ireland Limited |
Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti
|
PT2424356T
(pt)
|
2009-04-29 |
2017-11-23 |
Amarin Pharmaceuticals Ie Ltd |
Composição farmacêutica estável e métodos de utilização das mesmas
|
AU2010241567B2
(en)
|
2009-04-29 |
2013-10-31 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
|
NZ620473A
(en)
*
|
2009-06-15 |
2015-09-25 |
Amarin Pharmaceuticals Ie Ltd |
Compositions and methods for lowering triglycerides without raising ldl-c levels
|
NZ599061A
(en)
|
2009-09-23 |
2014-05-30 |
Amarin Pharmaceuticals Ie Ltd |
Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
|
RU2538981C2
(ru)
*
|
2009-12-30 |
2015-01-10 |
Басф Фарма (Калланиш) Лимитед |
Способ хроматографического разделения с псевдодвижущимся слоем
|
ES2750365T3
(es)
*
|
2010-03-04 |
2020-03-25 |
Amarin Pharmaceuticals Ie Ltd |
Composición para el tratamiento y/o la prevención de enfermedades cardiovasculares
|
US20130292242A1
(en)
*
|
2010-10-13 |
2013-11-07 |
Cognis Ip Management Gmbh |
Device and method for distilling temperature-sensitive substances
|
US20140127289A1
(en)
|
2010-11-29 |
2014-05-08 |
Armarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
US8951514B2
(en)
|
2011-02-16 |
2015-02-10 |
Pivotal Therapeutics Inc. |
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
|
US9119826B2
(en)
|
2011-02-16 |
2015-09-01 |
Pivotal Therapeutics, Inc. |
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
|
ES2395320B1
(es)
|
2011-07-14 |
2013-12-18 |
Soluciones Extractivas Alimentarias, S.L. |
Nuevo método para la reducción de contaminantes en grasas y aceites a partir de aceites y sus derivados.
|
CN102391112B
(zh)
*
|
2011-10-31 |
2014-06-04 |
赵永俊 |
一种工业化生产二十碳五烯酸乙酯的方法
|
US11291643B2
(en)
|
2011-11-07 |
2022-04-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
WO2013070735A1
(en)
|
2011-11-07 |
2013-05-16 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
WO2013083482A1
(en)
|
2011-12-05 |
2013-06-13 |
Chromacon Ag |
Chromatographic method for the separation of fatty acid mixtures
|
EP2800469B1
(en)
|
2012-01-06 |
2021-08-25 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
|
CA2873160C
(en)
|
2012-05-14 |
2024-02-27 |
Nobushige Doisaki |
Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
|
UA118015C2
(uk)
|
2012-06-29 |
2018-11-12 |
Амарін Фармасьютікалз Айрленд Лімітед |
Способи зменшення ризику розвитку серцево-судинної події у суб'єкта, що одержує терапію статином
|
EP2902020A4
(en)
*
|
2012-09-28 |
2016-03-23 |
Mochida Pharm Co Ltd |
COMPOSITION FOR REDUCING NEW DIABETES APPARITIONS
|
US20150265566A1
(en)
|
2012-11-06 |
2015-09-24 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
|
US10123986B2
(en)
|
2012-12-24 |
2018-11-13 |
Qualitas Health, Ltd. |
Eicosapentaenoic acid (EPA) formulations
|
US9629820B2
(en)
|
2012-12-24 |
2017-04-25 |
Qualitas Health, Ltd. |
Eicosapentaenoic acid (EPA) formulations
|
US9814733B2
(en)
|
2012-12-31 |
2017-11-14 |
A,arin Pharmaceuticals Ireland Limited |
Compositions comprising EPA and obeticholic acid and methods of use thereof
|
US20140187633A1
(en)
|
2012-12-31 |
2014-07-03 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
|
GB201300354D0
(en)
|
2013-01-09 |
2013-02-20 |
Basf Pharma Callanish Ltd |
Multi-step separation process
|
US9452151B2
(en)
|
2013-02-06 |
2016-09-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing apolipoprotein C-III
|
US9624492B2
(en)
|
2013-02-13 |
2017-04-18 |
Amarin Pharmaceuticals Ireland Limited |
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
|
US9662307B2
(en)
|
2013-02-19 |
2017-05-30 |
The Regents Of The University Of Colorado |
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
|
US9283201B2
(en)
|
2013-03-14 |
2016-03-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating or preventing obesity in a subject in need thereof
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
EP2801604B1
(en)
|
2013-05-07 |
2017-04-12 |
Groupe Novasep |
Chromatographic process for the production of highly purified polyunsaturated fatty acids
|
US9428711B2
(en)
|
2013-05-07 |
2016-08-30 |
Groupe Novasep |
Chromatographic process for the production of highly purified polyunsaturated fatty acids
|
US10966968B2
(en)
|
2013-06-06 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
|
US20150065572A1
(en)
|
2013-09-04 |
2015-03-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing prostate cancer
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
US9820484B2
(en)
*
|
2013-12-04 |
2017-11-21 |
Nippon Suisan Kaisha, Ltd. |
Dihomo-γ-linolenic acid-containing microbial oil and dihomo-γ-linolenic acid-containing microbial biomass
|
EP2883860B1
(fr)
*
|
2013-12-11 |
2016-08-24 |
Novasep Process |
Procédé chromatographique de production d'acides gras polyinsaturés
|
KR102165406B1
(ko)
|
2014-01-07 |
2020-10-14 |
노바셉 프로세스 |
방향족 아미노산의 정제 방법
|
US10561631B2
(en)
|
2014-06-11 |
2020-02-18 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing RLP-C
|
WO2015195662A1
(en)
|
2014-06-16 |
2015-12-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
|
CN106459833A
(zh)
*
|
2014-07-02 |
2017-02-22 |
日本水产株式会社 |
源自水产物的游离一元不饱和脂肪酸或其低级醇酯的制造方法
|
DE202015009883U1
(de)
*
|
2014-09-17 |
2021-01-15 |
Mochida Pharmaceutical Co. Ltd. |
Eicosapentaensäurealkylester enthaltende Zusammensetzung
|
AU2016336354B2
(en)
*
|
2015-10-05 |
2021-04-15 |
Dsm Ip Assets B.V. |
Oil compositions and methods of making
|
US10406130B2
(en)
|
2016-03-15 |
2019-09-10 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
US10966951B2
(en)
|
2017-05-19 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject having reduced kidney function
|
US11058661B2
(en)
|
2018-03-02 |
2021-07-13 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
|
EP3750536A1
(en)
|
2018-09-24 |
2020-12-16 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of cardiovascular events in a subject
|
CN109438220B
(zh)
*
|
2018-10-31 |
2021-04-13 |
苏州赛分科技有限公司 |
一种从鱼油中纯化epa的方法
|
EP4049537A1
(en)
|
2018-12-12 |
2022-08-31 |
Nippon Suisan Kaisha, Ltd. |
A composition containing highly unsaturated fatty acid or alkyl ester thereof and a method for producing the same
|
EP4086621A4
(en)
*
|
2021-03-17 |
2024-06-12 |
Nissui Corporation |
PURIFICATION PROCESS AND PURIFIED PRODUCT
|
WO2022225896A1
(en)
|
2021-04-21 |
2022-10-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of heart failure
|